Progressive augmentation of striatal and accumbal preprotachykinin mRNA levels by chronic treatment with methamphetamine and effect of concurrent administration of the N-methyl-D-aspartate receptor antagonist MK-801

Neuropharmacology

Volumn 36, Issue 3, 1997, Pages 325-334

  Zhang, Yong ^a   Landas, K ^a   Mueller, H ^a   Angulo, J A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

accumbens; methamphetamine; MK 801; preproenkephalin mRNA; preprotachykinin mRNA; striatum

Indexed keywords

DIZOCILPINE; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE MRNA; PREPROENKEPHALIN MRNA; PREPROTACHYKININ MRNA; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DOSE TIME EFFECT RELATION; DRUG WITHDRAWAL; GENE EXPRESSION; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RAT; SENSITIZATION; TISSUE DISTRIBUTION;

ANIMALS; DIZOCILPINE MALEATE; DRUG SYNERGISM; MALE; METHAMPHETAMINE; NUCLEUS ACCUMBENS; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TACHYKININS; TIME FACTORS; VISUAL CORTEX;

EID: 0030947175     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00005-1     Document Type: Article

References (50)

1. Angulo J.A. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain. J. Neurochem. 58:1992;1104-1109.
2. Angulo J.A., McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19:1994;1-28.
3. Angulo J., Cadet J., Woolley C., Suber F., McEwen B. Effect of chronic typical and atypical neuroleptic treatment on proenkephalin mRNA levels in the striatum and nucleus accumbens of the rat. J. Neurochem. 54:1990;1889-1894.
4. Araneda R., Bustos G. Modulation of dendritic release of dopamine by N-methyl-D-aspartate receptors in rat substantia nigra. J. Neurochem. 52:1989;962-970.
5. Azzaro A., Rutledge C.O. Selectivity of release of norepinephrine, dopamine and 5-hydroxy-tryptamine by amphetamine in various regions of rat brain. Biochem. Pharmacol. 22:1973;2801-2813.
6. Bannon M., Lee J.-M., Giraud P., Affolter H.-U., Bonner T. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. J. Biol. Chem. 261:1986;6640-6644.
7. Bjorkland A. and Lindvall O. (1984) In: Handbook of Chemical Neuroanatomy: Classical Transmitters in the CNS, Part 1 (Bjorkland A. and Hokfeltl T., Eds), pp. 55-122. Elsevier, Amsterdam.
8. Fallon J., Moore R. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum J. Comp. Neurol. 180:1978;545-580.
9. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Ann. Rev. Neurosci. 15:1992;285-320.
10. Gerfen C.R., McGinty J.F., Young W.S. III Dopamine differentially regulates dynorphin, substance P and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
11. Greenamyre J.T., Young A.B. Synaptic localization of striatal NMDA, quisqualate and kainate receptors. Neurosci. Lett. 101:1989;133-137.
12. Hong J.-S., Yang T., Gillin J., Costa E. Effects of long-term administration of antipsychotic drugs on enkephalinergic neurons. Adv. Biochem. Psychopharmacol. 24:1980;223-232.
13. James T.A., Starr M.S. Behavioral and biochemical effects of substance P injected into the substantia nigra of the rat. J. Pharm. Pharmacol. 29:1977;181-182.
14. Kalivas P.W. Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon. Neurosci. Behav. Rev. 9:1985;573-587.
15. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
16. Kashihara K., Hamamura T., Okumura K., Otsuki S. Effect of MK-801 on endogenous dopamine release in vivo. Brain Res. 528:1990;80-82.
17. Kelly A., Cador M., Stinus L. Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. Psychopharmacology (Berlin). 85:1985;37-46.
18. Kornetsky C., Esposito R. Reward and detection thresholds for brain stimulation: dissociation effects of cocaine. Brain Res. 209:1981;496-500.
19. Krause J., Chirgwin J., Carter M., Xu Z., Hershey A. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natn. Acad. Sci. U.S.A. 84:1987;881-885.
20. Krebs M., Desce J., Kemel M., Gauchy C., Godeheu G., Cheramy A., Glowinski J. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56:1991;81-85.
21. Li S., Jiang H., Stachowiak M., Hudson P., Owyang V., Nanry K., Tilson H., Hong J. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin inin rat brain in rat striatum. Brain Res. 8:1990;219-225.
22. Morari M., O'Connor W.T., Ungerstedt U., Fuxe K. NMDA differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthesized rat: an in vivo microdialysis study. J. Neurochem. 60:1993;1884-1893.
23. Le Moal M., Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 7:1991;1155-1233.
24. Moore K.E. (1978) Amphetamines: biochemical and behavioral actions in animals. In: Handbook of Psychopharmacology (Iversen L.L., Iversen S.D. and Snyder S.H., Eds), pp.41-98. Plenum Press, New York.
25. Nelson L.R., Ellison G. Enhanced stereotypes after repeated injections but not continuous amphetamines. Neuropharmacology. 17:1978;1081-1084.
26. Olpe H.R., Koella W.P. Rotary behaviour in rats by intra-nigral application of substance P and an eledoisin fragment. Brain Res. 126:1977;576-579.
27. Paulson P.E., Camp D.M., Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology. 103:1991;480-492.
28. Paulson P.E., Robinson T.E. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse. 19:1995;56-65.
29. Pellegrino L.J., Pellegrino A.S. and Cushman A.J. (1979) A Stereotaxic Atlas of the Rat Brain. Plenum, New York.
30. Pierce R.C., Duffy P., Kalivas P.W. Sensitization to cocaine and dopamine autoreceptor subsensitivity in the nucleus accumbens. Synapse. 20:1995;33-36.
31. Post R.M. Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sci. 261:1980;275-1282.
32. Roberts D., Koob G. Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol. Biochem. Behav. 17:1982;901-904.
33. Roberts P.J., McBean G.J., Sharif N.A., Thomas E.M. Striatal glutamatergic function: modifications following specific lesions. Brain Res. 235:1982;83-91.
34. 3H]dopamine from rat striatal slices. Brain Res. 157:1978;391-395.
35. Robinson T., Becker J. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
36. Romano G., Shivers B., Harlan R., Howells R., Pfaff D. Haloperidol increases proenkephalin mRNA levels in the caudate-putamen of the rat: a quantitative study at the cellular level using in situ hybridization. Mol. Brain Res. 2:1987;33-41.
37. Rosen H., Douglass J., Herbert E. Isolation and characterization of the rat proenkephalin gene. J. Biol. Chem. 259:1984;14309-14313.
38. Self D.W., Nestler E.J. Molecular mechanisms of drug reinforcement and addiction. Ann. Rev. Neurosci. 18:1995;463-495.
39. Somers D.L., Beckstead R.M. N-Methyl-D-aspartate receptor antagonism alters substance P and met5-enkephalin biosynthesis in neurons of the rat striatum. J. Pharmacol. Exp. Ther. 262:1992;823-833.
40. Stinus L., Kelly A., Iversen S. Increased spontaneous activity following substance P infusion into A10 dopaminergic area. Nature. 276:1978;616-618.
41. Voorn P., Roest G., Groenewegen H.J. Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions. Brain Res. 412:1987;391-396.
42. Wang J. Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes. J. Neurochem. 57:1991;819-822.
43. Wang J.Q., McGinty J.F. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673:1995;262-274.
44. Wolf M.E., Khansa M.R. Repeated administration of MK 801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562:1991;164-168.
45. Wolf M.E., White F.J., Hu X.-T. MK 801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J. Neurosci. 14:1994;1735-1745.
46. Yokel R., Wise R. Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science. 187:1975;547-549.
47. Young W.S. III, Bonner T.I., Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natn. Acad. Sci. U.S.A. 83:1986;9827-9831.
48. Zhang F., Van Bree L., Albala N., Verslype M., Vanderhaeghen J.-J. NMDA receptor antagonist MK-801 down-regulates rat striatal proenkephalin and protachykinin mRNAs. Neurochem. Int. 28:1996;189-192.
49. Zhang J., Chiodo L.A., Freeman A.S. Electrophysiological effects of mk-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res. 590:1992;158-163.
50. Zhang Y., Angulo J. Contrasting effects of repetitive treatment versus withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA abundance in ventral tegmental area and substantia nigra zona compacta of the rat brain. Synapse. 24:1996;218-223.